The global genomics market was valued at USD 27.75 billion in 2023 and is expected to grow to USD 30.75 billion in 2024, reaching USD 80.17 billion by 2032, with a CAGR of 12.7% during the forecast period.
Genomics has demonstrated its potential in disease prevention, management, and treatment, driving a shift in healthcare from traditional methods to precision medicine. Over recent years, its exceptional clinical applications have accelerated this transition. Whole genome sequencing has become a vital tool in diagnosing critical diseases like cancer. For instance, the National Cancer Institute predicts that by 2040, there will be 29.5 million new cancer cases annually, with 16.4 million cancer-related deaths. The growing need for DNA storage, sequencing, and analysis has spurred the development of innovative products and software, significantly boosting the genomics market.
Read More : https://www.fortunebusinessinsights.com/industry-reports/genomics-market-100941
Top Companies in the Genomics Market
- Illumina, Inc. (U.S.)
- Thermo Fisher Scientific Inc. (U.S.)
- F. Hoffmann-La Roche Ltd. (Switzerland)
- Agilent Technologies, Inc. (U.S.)
- Oxford Nanopore Technologies (U.K.)
- Danaher (U.S.)
- QIAGEN (Germany)
- BGI (China)
- IntegraGen (France)
- General Electric Company (U.S.)
Key Industry Development
In January 2024, Gencove and Ferris Genomics announced a strategic collaboration to deliver end-to-end genomics sequencing services. This partnership is expected to enhance the accessibility and efficiency of genetic sequencing for research and clinical applications, marking a significant step forward in the genomics market.
Market Drivers & Restraints
Market Drivers
Several factors are driving the growth of the genomics market:
- Advancements in Genomic Technologies: Continuous innovation in sequencing technologies has made genetic analysis faster and more cost-effective.
- Growing Adoption in Precision Medicine: Genomics plays a critical role in personalized healthcare by enabling tailored treatments based on genetic profiles.
- Increasing Research Activities: Expanding research initiatives in genetics and genomics are boosting the demand for advanced sequencing tools and services.
- Government Funding and Support: Substantial investments from governments worldwide to enhance genomics infrastructure are accelerating market growth.
Market Restraints
Despite the promising growth, the genomics market faces certain challenges:
- High Costs: Advanced genomic technologies and instruments are expensive, limiting their accessibility to smaller organizations.
- Data Privacy Concerns: The storage and sharing of genetic data raise significant ethical and privacy issues.
- Lack of Skilled Professionals: The shortage of experts in genomics and bioinformatics poses a challenge to market expansion.
Market Report Coverage
The genomics market report provides comprehensive insights, including:
- Market size, growth potential, and emerging trends.
- Technological advancements shaping the industry.
- Competitive landscape with profiles of key players.
- Segmentation by product type, application, and region.
- Challenges, opportunities, and strategies for market growth.
Market Competitive Landscape
The genomics market is highly competitive, with major players like Illumina, Inc., Thermo Fisher Scientific Inc., and Oxford Nanopore Technologies driving innovation. These companies are focusing on strategic partnerships, product launches, and research collaborations to strengthen their market position. New entrants are leveraging niche opportunities to make an impact in this dynamic market.
Market Segments
Product Segment Leads the Market
The product segment dominates the genomics market, driven by the growing demand for sequencing instruments, reagents, and software solutions. These products are essential for research and clinical applications, making them a cornerstone of the genomics industry. Continuous advancements in product offerings are further enhancing their adoption across various sectors.
Market Regional Insights
The regional analysis highlights the following trends:
- North America: The largest market for genomics, fueled by advanced healthcare infrastructure, high R&D investments, and the presence of leading companies.
- Europe: A significant market driven by increasing research initiatives and government funding for genomics projects.
- Asia-Pacific: The fastest-growing region, supported by rising healthcare investments, expanding biotechnology sectors, and a growing focus on precision medicine.
- Rest of the World: Emerging markets in Latin America and the Middle East are witnessing steady growth due to improving healthcare infrastructure and increasing awareness of genomic applications.
Future Market Scope
The future of the genomics market is bright, with advancements in artificial intelligence, machine learning, and big data analytics paving the way for more efficient and accurate genomic analysis. The growing adoption of direct-to-consumer genetic testing, combined with an increasing focus on rare disease research, will further expand the market's scope. As the genomics industry continues to evolve, it holds immense potential to revolutionize healthcare and biotechnology.
Purchase Full Report at -https://www.fortunebusinessinsights.com/checkout-page/100941
About Us:
Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in. Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.
Contact Us:
Fortune Business Insights™ Pvt. Ltd.
9th Floor, Icon Tower,
Baner - Mahalunge Road,
Baner, Pune-411045,
Maharashtra, India.
Phone:
US: +1 424 253 0390
UK: +44 2071 939123
APAC: +91 744 740 1245
Email: sales@fortunebusinessinsights.com
